Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC)-Reference-Cited by-同舟云学术

Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC)

Published:2022-10 Issue: Volume:626 Page:122131
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Twarog Caroline,Fattal Elias,Noiray Magali,Illel Brigitte,Brayden David J.,Taverna Myriam,Hillaireau Hervé

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference38 articles.

1. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials;Aguirre;Adv. Drug Deliv. Rev.,2016

2. High-throughput viscosity measurement using capillary electrophoresis instrumentation and its application to protein formulation;Allmendinger;J. Pharm. Biomed. Anal.,2014

3. Isothermal titration calorimetric studies on the interaction of the major bovine seminal plasma protein, PDC-109 with phospholipid membranes;Anbazhagan;PloS One,2011

4. On the mechanism of SDS-induced protein denaturation;Bhuyan;Biopolymers,2010

5. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells;Brayden;Eur. J. Pharm. Biopharm.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of mucoadhesive 3D-printed Carbopol/Eudragit/SNAC tablets for the oral delivery of enoxaparin: In vitro and ex vivo evaluation;International Journal of Pharmaceutics;2024-10

2. Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC ‐ What is Coming Next?;Advanced Science;2024-06-17

3. Glucagon-like peptide-1 analogs: Miracle drugs are blooming?;European Journal of Medicinal Chemistry;2024-04

4. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments;International Journal of Pharmaceutics;2024-04